Rates And Predictors Of Hbsag Loss After Discontinuation Of Effective Long-Term Entecavir Or Tenofovir Therapy In Non-Cirrhotic Hbeag-Negative Chronic Hepatitis B Patients: Results From The Daring-B Prospective Greek Study